Sanjun Cai
Fudan University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sanjun Cai as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:09 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07877597 · Chemotherapy Combined With or Without Short-Course Radiotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for High-Risk Locally Advanced Colon Cancer With pMMR/MSSFudan University · not yet recruiting · Locally Advanced Colon Cancer, pMMR · principal investigator
- Ph4NCT06090994 · Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine MonotherapyFudan University · recruiting · Colorectal Cancer · principal investigator
- N/ANCT03404934 · Clinical Study Verifying C-REX LapAid in Clinical PracticeCarponovum AB · terminated · Cancer Colonic · principal investigator
- Ph2NCT01322178 · Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer PatientsFudan University · unknown · Colorectal Cancer, Liver Metastases · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in colorectal cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:09 UTC. The ranking covers the 200 most relevant of 36 PubMed records, and a shared surname and initials can bring in a namesake. All 36 on PubMed
- Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies.EBioMedicine · 2017147 citationsRCR 4.8
- Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH).J Clin Oncol · 2024124 citationsRCR 13.8
- 112 citationsRCR 4.7
- Letter to the Editor: An ultra-sensitive assay using cell-free DNA fragmentomics for multi-cancer early detection.Mol Cancer · 202260 citationsRCR 3.7
- Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study.Radiat Oncol · 201457 citationsRCR 2.1
- 46 citationsRCR 2.8
- Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study.Colorectal Dis · 201145 citationsRCR 1.7
- Short-term outcomes of laparoscopic total mesorectal excision compared to open surgery.World J Gastroenterol · 201241 citationsRCR 1.5
- Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.World J Gastroenterol · 201337 citationsRCR 1.5
- A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma.Radiat Oncol · 201332 citationsRCR 1.0